Alumis Inc. (ALMS) Stock Forecast
Data as of Oct 31, 2026Healthcare · Current price $6.67 (-3.27%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 10, 2026 | Christopher Raymond | Raymond James | $46.00 | +590.2% |
| Jan 21, 2026 | Janani Sundararajan | Loop Capital Markets | $37.00 | +455.1% |
| Jan 7, 2026 | Yatin Suneja | Guggenheim | $32.00 | +380.1% |
| Jan 6, 2026 | Jeff Jones | Oppenheimer | $50.00 | +650.2% |
| Jan 6, 2026 | Derek Archila | Wells Fargo | $39.00 | +485.1% |
| Dec 18, 2025 | Mitchell Kapoor | H.C. Wainwright | $20.00 | +200.1% |
| Oct 30, 2024 | Brian Skorney | Robert W. Baird | $25.00 | +275.1% |
| Oct 17, 2024 | Mitchell Kapoor | H.C. Wainwright | $30.00 | +350.1% |
| Jul 23, 2024 | Eric Schmidt | Cantor Fitzgerald | $13.00 | +95.0% |
Top Analysts Covering ALMS
ALMS vs Sector & Market
| Metric | ALMS | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.36 | 2.25 | 2.41 |
| Analyst Count | 11 | 8 | 19 |
| Target Upside | +343.7% | +153002.0% | +21.5% |
| P/E Ratio | -10.34 | 3.48 | 38.49 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1M | $2M | $4M | 5 |
| 2027-03-31 | $1M | $2M | $4M | 3 |
| 2027-06-30 | $1M | $2M | $4M | 3 |
| 2027-09-30 | $1M | $2M | $4M | 3 |
| 2027-12-31 | $1M | $2M | $4M | 3 |
| 2028-12-31 | $173M | $173M | $173M | 8 |
| 2029-12-31 | $250M | $422M | $577M | 7 |
| 2030-12-31 | $497M | $840M | $1.15B | 7 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-1.57 | $-0.71 | $-0.28 | 2 |
| 2027-03-31 | $-1.60 | $-0.72 | $-0.28 | 2 |
| 2027-06-30 | $-1.53 | $-0.69 | $-0.27 | 1 |
| 2027-09-30 | $-1.44 | $-0.65 | $-0.25 | 1 |
| 2027-12-31 | $-1.42 | $-0.64 | $-0.25 | 2 |
| 2028-12-31 | $-2.88 | $-1.97 | $-1.06 | 7 |
| 2029-12-31 | $-1.42 | $-0.96 | $-0.45 | 2 |
| 2030-12-31 | $0.44 | $0.93 | $1.37 | 5 |
Frequently Asked Questions
What is the analyst consensus for ALMS?
The consensus among 11 analysts covering Alumis Inc. (ALMS) is Buy with an average price target of $29.57.
What is the highest price target for ALMS?
The highest price target for ALMS is $50.00, set by Jeff Jones at Oppenheimer on 2026-01-06.
What is the lowest price target for ALMS?
The lowest price target for ALMS is $13.00, set by Eric Schmidt at Cantor Fitzgerald on 2024-07-23.
How many analysts cover ALMS?
11 analysts have issued ratings for Alumis Inc. in the past 12 months.
Is ALMS a buy or sell right now?
Based on 11 analyst ratings, ALMS has a consensus rating of Buy (2.36/5) with a +343.7% upside to the consensus target of $29.57.
What are the earnings estimates for ALMS?
Analysts estimate ALMS will report EPS of $-0.71 for the period ending 2026-12-31, with revenue estimated at $2M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.